SpheroFill, LLC

SpheroFill, LLC is a biotechnology and pharmaceutical startup with a compelling vision for the future of drug delivery. Founded in 2017 and headquartered in the United States, its slogan, "Next-generation drug delivery platform capable of protecting, delivering, and releasing API as solid, liquid, even gas," encapsulates the innovative nature of the company. SpheroFill's drug delivery platform is designed to protect, deliver, and release active pharmaceutical ingredients in various forms, including solid, liquid, or gas. The use of glass microspheres not only enhances patient compliance by reducing dose frequency but also enables oral formulations previously beyond the reach of existing technology. The most recent milestone for SpheroFill is the receipt of a $255.39K grant investment on 13 May 2021 from the National Science Foundation. This injection of funds represents a vote of confidence in the potential of the startup's groundbreaking approach to drug delivery. With its focus on addressing critical challenges in the pharmaceutical industry, SpheroFill, LLC, is poised to make a significant impact with its innovative technology.